Serena Williams' revelation on Thursday that she'd lost 31 pounds came with another confession. Fans were angered with ...

Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...

Serena Williams stole the spotlight in Manhattan on Thursday night, dazzling at a glitzy US Open kickoff party just weeks ...

Caleb Luna, assistant professor of feminist studies at the University of California, says having someone like Serena Williams ...

GLP-1 meds are trending after Serena Williams’ 31-pound weight loss. A doctor breaks down the side effects, safety concerns & ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

American tennis legend Serena Williams revealed taking the help of GLP-1 drugs to attain an ideal figure after struggling to ...

While diet and exercise remain the foundation for many, more and more stars are openly admitting to using weight-loss ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...